Found: 20
Select item for more details and to access through your institution.
Translation of Monoclonal Antibodies Pharmacokinetics from Animal to Human Using Physiologically Based Modeling in Open Systems Pharmacology (OSP) Suite: A Retrospective Analysis of Bevacizumab.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2129, doi. 10.3390/pharmaceutics15082129
- By:
- Publication type:
- Article
Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091844
- By:
- Publication type:
- Article
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 8, p. 804, doi. 10.3390/ph14080804
- By:
- Publication type:
- Article
Improving olaparib exposure to optimize adverse effects management.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359241248328
- By:
- Publication type:
- Article
A Minimal PBPK Model for Plasma and Cerebrospinal Fluid Pharmacokinetics of Trastuzumab after Intracerebroventricular Administration in Patients with HER2-Positive Brain Metastatic Localizations.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2687, doi. 10.1007/s11095-023-03614-w
- By:
- Publication type:
- Article
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer.
- Published in:
- Thyroid, 2023, v. 33, n. 11, p. 1327, doi. 10.1089/thy.2023.0228
- By:
- Publication type:
- Article
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4566, doi. 10.3390/cancers14194566
- By:
- Publication type:
- Article
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 931, doi. 10.3390/cancers12040931
- By:
- Publication type:
- Article
Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 762, doi. 10.3390/cancers11060762
- By:
- Publication type:
- Article
Model‐Based Quantification of Impact of Genetic Polymorphisms and Co‐Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 5, p. 1244, doi. 10.1002/cpt.2077
- By:
- Publication type:
- Article
Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 3, p. 585, doi. 10.1002/cpt.1404
- By:
- Publication type:
- Article
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 5, p. 413, doi. 10.1007/s00280-023-04520-z
- By:
- Publication type:
- Article
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 5, p. 361, doi. 10.1007/s00280-023-04508-9
- By:
- Publication type:
- Article
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1866, doi. 10.1038/s41416-024-02659-x
- By:
- Publication type:
- Article
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 6, p. 961, doi. 10.1038/s41416-024-02585-y
- By:
- Publication type:
- Article
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1025, doi. 10.1007/s40262-024-01396-x
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of the Interaction of Amino Acid Infusion on <sup>177</sup>Lu-Dotatate Pharmacokinetics in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article